quipazine has been researched along with Paralysis in 2 studies
Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ung, RV | 1 |
| Landry, ES | 1 |
| Rouleau, P | 1 |
| Lapointe, NP | 1 |
| Rouillard, C | 1 |
| Guertin, PA | 1 |
| White, SR | 1 |
| Bieger, D | 1 |
2 other studies available for quipazine and Paralysis
| Article | Year |
|---|---|
Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
Topics: Animals; Disease Models, Animal; Hindlimb; Male; Mice; Motor Activity; Movement; Nerve Net; Paralysi | 2008 |
Central serotonin receptor sensitivity in rats with experimental allergic encephalomyelitis.
Topics: 5-Hydroxytryptophan; Animals; Brain Stem; Deglutition; Encephalomyelitis, Autoimmune, Experimental; | 1980 |